new
   Indications for Vadadustat (Vafseo)
501
Oct 27, 2025

Vadadustat (Vafseo) is a hypoxia-inducible factor prolyl hydroxylase (HIFPH) inhibitor, used for the treatment of anemia caused by chronic kidney disease (CKD).

Indications for Vadadustat (Vafseo)

Indications

Primary Indication: Used for the treatment of anemia in adult patients with chronic kidney disease (CKD) on dialysis, with the requirement that the patient has been on continuous dialysis for at least 3 months.

Combination Therapy: Must be used in combination with standard therapies such as iron supplementation, but cannot replace blood transfusion therapy.

Key Limitations

It has not been proven to improve quality of life, reduce fatigue, or enhance patients' overall health status.

Contraindicated in non-dialysis CKD patients with anemia and in situations requiring blood transfusion as a substitute for immediate anemia correction.

Dosage Form, Strength and Properties of Vadadustat (Vafseo)

Dosage Form and Strength

Tablets: Available in three strengths: 150 mg (round/white), 300 mg (oval/yellow), and 450 mg (oval/pink). Each tablet is marked with "VDT" and the corresponding dosage number on its surface.

Ingredient Characteristics

Active Ingredient: Vadadustat (chemical name: 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid), with a molecular weight of 306.70.

Excipients: Include colloidal silicon dioxide, hypromellose, magnesium stearate, etc. The film coating contains polyvinyl alcohol, polyethylene glycol, and talc.

Physicochemical Properties

It is a white to off-white crystalline solid, almost insoluble in water, and easily soluble in organic solvents.

Storage Methods for Vadadustat (Vafseo)

Storage Conditions

Temperature Requirement: Store at 20°C to 25°C (68°F to 77°F), with short-term exposure to 15°C to 30°C (59°F to 86°F) allowed.

Packaging Form: 60 tablets per bottle, equipped with a child-resistant cap.

Precautions

Avoid exposure to high temperatures, moisture, or freezing environments.

Keep the bottle cap tightly closed to prevent the medication from absorbing moisture or being contaminated.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Vadadustat(Vafseo)
Treatment of anemia in adults with chronic kidney disease (CKD) who have been on dialysis for at least three months.
RELATED ARTICLES
How to Use Vadadustat (Vafseo)

Vadadustat (Vafseo) is a hypoxia-inducible factor prolyl hydroxylase (HIFPH) inhibitor, indicated for the treatment...

Monday, October 27th, 2025, 10:41
Indications for Vadadustat (Vafseo)

Vadadustat (Vafseo) is a hypoxia-inducible factor prolyl hydroxylase (HIFPH) inhibitor, used for the treatment of...

Monday, October 27th, 2025, 10:36
How to Purchase Vadadustat (Vafseo)

Vadadustat (Vafseo) is an oral medication used to treat anemia in dialysis patients with chronic kidney disease...

Monday, October 27th, 2025, 10:32
RELATED MEDICATIONS
Vadadustat
Treatment of anemia in adults with chronic kidney disease (CKD) who have been...
TOP
1
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved